+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Poultry Vaccine Market - Global Forecast 2026-2032- Product Image
Poultry Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Poultry Vaccine Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968978
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Poultry Vaccine Market is projected to reach USD 3.00 Billion in 2026. It is expected to continue growing at a CAGR of 6.26%, reaching USD 4.37 Billion by 2032.

The poultry vaccine market is a critical pillar of global animal health, food security, and antimicrobial stewardship. Vaccines for broilers, layers, and breeders help prevent high-impact diseases such as Newcastle disease, infectious bronchitis, infectious bursal disease, Marek’s disease, avian influenza, fowl pox, coccidiosis, and salmonellosis. These diseases can reduce flock productivity, increase mortality, disrupt trade, and raise the need for therapeutic interventions.

Demand is being reinforced by expanding poultry meat and egg consumption, stricter biosecurity expectations, and the economic importance of uninterrupted poultry supply chains. Verified guidance from organizations such as WOAH, FAO, WHO, USDA, and national veterinary authorities confirms that vaccination, when integrated with surveillance and farm-level biosecurity, remains one of the most effective tools for controlling endemic and transboundary poultry diseases.

Transformative Shifts in the Poultry Vaccine Landscape

The landscape is shifting from reactive disease treatment toward preventive flock health management. Producers are prioritizing vaccination schedules that protect day-old chicks, reduce production losses, and support consistent feed conversion performance. Hatchery-based vaccination, in-ovo delivery, and mass administration methods are gaining relevance because they improve coverage and reduce labor intensity across large commercial operations.

Another major shift is the rise of advanced vaccine platforms, including recombinant, vector-based, immune-complex, subunit, and live-attenuated products. These technologies are improving protection against evolving pathogens and enabling more targeted disease control. At the same time, regulators and buyers are placing greater emphasis on residue reduction, antimicrobial use reduction, traceability, documented flock health outcomes, and alignment with One Health principles.

Cumulative Impact of Artificial Intelligence on Poultry Vaccines

Artificial intelligence is beginning to influence poultry vaccine development, disease surveillance, and field execution. AI-enabled epidemiological modeling can help identify disease spread patterns, evaluate outbreak risk, and support decisions on vaccination timing. In research and development, machine learning can accelerate antigen screening, immune-response modeling, and strain selection for diseases with high mutation pressure.

AI also improves farm-level vaccine performance monitoring. Computer vision, environmental sensors, production analytics, and mortality pattern analysis can help detect early health deviations after vaccination or disease exposure. However, AI does not replace regulatory validation, challenge studies, cold-chain controls, or veterinary oversight. Its greatest value lies in making vaccination programs more predictive, measurable, and responsive.

Key Regional Insights Across Poultry Vaccine Adoption

Asia-Pacific remains central to poultry vaccine demand due to large poultry populations, intensive production systems, and recurring pressure from Newcastle disease, infectious bronchitis, infectious bursal disease, and avian influenza. China and India continue to shape regional volume, while Southeast Asian countries are strengthening biosecurity and vaccination infrastructure through commercial integration and national disease-control programs. North America is characterized by science-based veterinary oversight, strong hatchery vaccination adoption, and heightened avian influenza preparedness following recent highly pathogenic avian influenza events documented by USDA and CFIA.

Latin America, led by Brazil and Mexico, benefits from export-oriented poultry production and structured disease-control programs that prioritize flock health, traceability, and continuity of trade. Europe is driven by strict animal health regulation, advanced surveillance, and EU-level disease notification systems, with vaccination strategies shaped by risk-based control, welfare expectations, and antimicrobial reduction goals. The Middle East depends on vaccine-supported poultry self-sufficiency initiatives, particularly where climate stress, water constraints, and import dependence create supply risk. Africa shows strong long-term need as vaccination against Newcastle disease remains essential for both commercial farms and backyard poultry systems, where poultry contributes to nutrition, household income, and rural resilience.

Key Group Insights for Poultry Vaccine Strategy

ASEAN markets are expanding poultry vaccination programs as commercial integrators modernize hatcheries and governments strengthen avian disease surveillance, particularly for Newcastle disease and avian influenza. The GCC is focused on food security, domestic poultry capacity, and vaccine-supported biosecurity in high-temperature production environments where flock stress can increase disease-management complexity. The European Union emphasizes harmonized veterinary regulation, pharmacovigilance, residue control, and disease reporting, making compliance, documentation, and post-authorization monitoring essential for suppliers.

BRICS countries represent a large share of global poultry production and are influential in volume demand, local manufacturing capability, and disease-control policy, with China, India, Brazil, Russia, and South Africa each facing distinct poultry health priorities. G7 markets are distinguished by advanced veterinary infrastructure, innovation funding, diagnostic capacity, and strong regulatory scrutiny. NATO countries overlap with several advanced animal health markets where resilience of food supply chains, outbreak readiness, and cross-border disease intelligence increasingly inform poultry vaccine procurement and biosecurity planning.

Key Country Insights in Poultry Vaccine Demand

The United States has one of the most developed poultry health ecosystems, supported by USDA disease surveillance, strong integrator networks, and widespread hatchery vaccination. Canada emphasizes coordinated animal health management and avian influenza preparedness, while Mexico combines large domestic poultry consumption with sustained demand for Newcastle disease, infectious bronchitis, infectious bursal disease, and coccidiosis control. Brazil’s export-focused poultry industry relies on robust vaccination and disease-prevention systems to protect international market access and support compliance with importing-country requirements.

In Europe, the United Kingdom, Germany, France, Italy, and Spain apply strict veterinary controls, with demand shaped by biosecurity, antimicrobial reduction, traceability, and poultry welfare expectations. Russia has a large domestic poultry base with continued emphasis on disease self-sufficiency, local supply reliability, and vaccination against endemic poultry pathogens. In Asia-Pacific, China and India anchor high-volume demand through large broiler and layer populations, Japan and South Korea prioritize advanced biosecurity, monitoring, and high-standard veterinary oversight, and Australia maintains strict animal health controls supported by quarantine, surveillance, and monitoring systems.

Actionable Recommendations for Poultry Vaccine Leaders

Industry leaders should align vaccine portfolios with disease prevalence, production type, and regulatory requirements in each market. Companies that combine core vaccines for Newcastle disease, infectious bronchitis, Marek’s disease, infectious bursal disease, coccidiosis, and salmonella with advanced recombinant or vector-based solutions will be better positioned to meet integrator needs.

Strategic priorities include strengthening cold-chain reliability, expanding hatchery-service capabilities, investing in AI-supported surveillance tools, and generating field evidence that demonstrates flock-level performance. Partnerships with veterinary authorities, universities, diagnostics providers, and poultry integrators can improve disease intelligence and accelerate product adoption. Leaders should also prepare for stricter documentation, pharmacovigilance, traceability, and sustainability expectations across export-oriented markets.

Research Methodology for Poultry Vaccine Insights

This executive summary is developed through secondary research and expert synthesis using verified public-domain sources, including WOAH disease information, FAO poultry health guidance, WHO antimicrobial resistance principles, USDA and CFIA avian influenza updates, European regulatory frameworks, and national veterinary authority publications. Market interpretation is grounded in disease burden, poultry production trends, regulatory signals, adoption patterns, and established veterinary immunization practices.

The methodology emphasizes triangulation across scientific literature, government disease surveillance, regulatory guidance, and industry practice. Insights are reviewed for relevance to commercial poultry vaccination, including broilers, layers, breeders, hatchery operations, and integrated production systems. No unsupported market-size, market-share, or forecasting claims are used; emphasis is placed on verifiable demand drivers and strategic implications.

Conclusion: Poultry Vaccines as a Food Security Imperative

Poultry vaccines will remain indispensable to animal health, protein security, and sustainable poultry production. As disease pressure intensifies and global trade becomes more sensitive to outbreaks, producers need vaccination programs that are scientifically validated, operationally practical, and supported by diagnostics, surveillance, and biosecurity.

The market’s next phase will be shaped by advanced vaccine platforms, stronger regional preparedness, AI-enabled decision support, and rising expectations for antimicrobial stewardship. Suppliers that deliver reliable products, field evidence, regulatory compliance, and integrated technical support will be best positioned to address long-term needs in the global poultry vaccine market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Poultry Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Live Attenuated Vaccines
7.2.1. Lentogenic
7.2.2. Mesogenic
7.2.3. Thermostable
7.3. Inactivated Vaccines
7.4. Conjugate Vaccines
7.5. Recombinant Vaccines
7.5.1. Vector-based Vaccines
7.5.2. Subunit Vaccines
7.5.3. DNA Vaccines
7.6. Toxoid Vaccines
8. Poultry Vaccine Market, by Species
8.1. Introduction
8.2. Chicken
8.3. Duck
8.4. Turkey
9. Poultry Vaccine Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Subcutaneous
9.3. Oral
9.4. Spray
9.4.1. Aerosol
9.4.2. Fogging
10. Poultry Vaccine Market, by End User
10.1. Introduction
10.2. Backyard Farms
10.3. Commercial Farms
10.3.1. Broiler Farms
10.3.2. Layer Farms
10.4. Research Institutes
11. Poultry Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Online Channels
11.2.1. E Commerce Marketplaces
11.2.2. Manufacturer Websites
11.3. Veterinary Hospitals
11.3.1. Government Hospitals
11.3.2. Private Hospitals
11.4. Veterinary Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Poultry Vaccine Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Poultry Vaccine Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Poultry Vaccine Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Biogénesis Bagó S.A.
16.2. Bioproperties Pty Ltd
16.3. Biovet S.A.
16.4. Bioveta, a.s.
16.5. Boehringer Ingelheim International GmbH
16.6. Ceva Santé Animale S.A.
16.7. China Animal Husbandry Industry Co., Ltd.
16.8. CZ Veterinaria S.A.
16.9. Elanco Animal Health Incorporated
16.10. Hester Biosciences Limited
16.11. HIPRA S.A.
16.12. Huvepharma EAD
16.13. Indian Immunologicals Ltd.
16.14. Indovax Private Limited
16.15. Jinyu Bio-Technology Co., Ltd.
16.16. KM Biologics Co., Ltd.
16.17. Merck & Co., Inc.
16.18. Neogen Corporation
16.19. Phibro Animal Health Corporation
16.20. SAN Group Biotech Germany GmbH
16.21. Tianjin Ringpu Bio-Technology Co., Ltd.
16.22. Vaksindo Satwa Nusantara
16.23. Vaxxinova International B.V.
16.24. Venky's India Limited
16.25. Vetoquinol S.A.
16.26. Virbac S.A.
16.27. Zoetis Inc.
16.28. Zydus Animal Health Limited
List of Figures
FIGURE 1. GLOBAL POULTRY VACCINE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL POULTRY VACCINE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL POULTRY VACCINE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL POULTRY VACCINE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2025 VS 2032 (%)
FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL POULTRY VACCINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL POULTRY VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LENTOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LENTOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LENTOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MESOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MESOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MESOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL THERMOSTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL THERMOSTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL THERMOSTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONJUGATE VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CONJUGATE VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CONJUGATE VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL VECTOR-BASED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL VECTOR-BASED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL VECTOR-BASED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL DNA VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DNA VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DNA VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL TOXOID VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TOXOID VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TOXOID VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CHICKEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CHICKEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CHICKEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DUCK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL DUCK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DUCK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TURKEY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TURKEY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TURKEY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL SPRAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL SPRAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL SPRAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AEROSOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AEROSOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL AEROSOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL FOGGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL FOGGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FOGGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL BACKYARD FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL BACKYARD FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL BACKYARD FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL COMMERCIAL FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BROILER FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BROILER FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL BROILER FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL LAYER FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL LAYER FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL LAYER FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ONLINE CHANNELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ONLINE CHANNELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ONLINE CHANNELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL E COMMERCE MARKETPLACES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL E COMMERCE MARKETPLACES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL E COMMERCE MARKETPLACES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL VETERINARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL GOVERNMENT HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL GOVERNMENT HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GOVERNMENT HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PRIVATE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL VETERINARY PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CHAIN PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CHAIN PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CHAIN PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL INDEPENDENT PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL INDEPENDENT PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL INDEPENDENT PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 156. EUROPE POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPE POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 159. EUROPE POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 160. EUROPE POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 161. EUROPE POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 162. EUROPE POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 163. EUROPE POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 164. EUROPE POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. EUROPE POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 166. EUROPE POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 167. EUROPE POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 168. EUROPE POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 169. EUROPE POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 184. AFRICA POULTRY VACCINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 185. AFRICA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 186. AFRICA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 187. AFRICA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 188. AFRICA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 189. AFRICA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 190. AFRICA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 191. AFRICA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 192. AFRICA POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. AFRICA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 194. AFRICA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 195. AFRICA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 196. AFRICA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 197. AFRICA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 198. GLOBAL POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 199. ASEAN POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. ASEAN POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 201. ASEAN POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 202. ASEAN POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 203. ASEAN POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 204. ASEAN POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 205. ASEAN POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 206. ASEAN POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 207. ASEAN POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. ASEAN POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 209. ASEAN POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 210. ASEAN POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 211. ASEAN POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 212. ASEAN POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 213. GCC POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. GCC POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 215. GCC POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 216. GCC POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 217. GCC POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 218. GCC POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 219. GCC POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 220. GCC POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 221. GCC POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. GCC POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 223. GCC POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 224. GCC POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 225. GCC POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 226. GCC POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 241. BRICS POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. BRICS POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 243. BRICS POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 244. BRICS POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 245. BRICS POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 246. BRICS POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 247. BRICS POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 248. BRICS POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 249. BRICS POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 250. BRICS POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 251. BRICS POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 252. BRICS POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 253. BRICS POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 254. BRICS POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 255. G7 POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. G7 POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 257. G7 POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 258. G7 POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 259. G7 POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 260. G7 POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 261. G7 POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 262. G7 POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 263. G7 POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 264. G7 POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 265. G7 POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 266. G7 POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 267. G7 POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 268. G7 POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 269. NATO POULTRY VACCINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. NATO POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 271. NATO POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 272. NATO POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 273. NATO POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 274. NATO POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 275. NATO POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 276. NATO POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 277. NATO POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. NATO POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 279. NATO POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 280. NATO POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 281. NATO POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 282. NATO POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 283. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 298. CANADA POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 299. CANADA POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 300. CANADA POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 301. CANADA POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 302. CANADA POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 303. CANADA POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 304. CANADA POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 305. CANADA POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 306. CANADA POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. CANADA POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 308. CANADA POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 309. CANADA POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 310. CANADA POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 311. CANADA POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 312. MEXICO POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. MEXICO POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 314. MEXICO POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 315. MEXICO POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 316. MEXICO POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 317. MEXICO POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 318. MEXICO POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 319. MEXICO POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 320. MEXICO POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. MEXICO POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 322. MEXICO POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 323. MEXICO POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 324. MEXICO POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 325. MEXICO POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 326. BRAZIL POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. BRAZIL POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 328. BRAZIL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 329. BRAZIL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 330. BRAZIL POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 331. BRAZIL POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 332. BRAZIL POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 333. BRAZIL POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 334. BRAZIL POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. BRAZIL POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 336. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 337. BRAZIL POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 338. BRAZIL POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 339. BRAZIL POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 340. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 341. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 342. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 343. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 344. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 345. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 346. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 347. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 348. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 349. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 350. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 351. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 352. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 353. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 354. GERMANY POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 355. GERMANY POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 356. GERMANY POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2017-2032 (USD MILLION)
TABLE 357. GERMANY POULTRY VACCINE MARKET SIZE, BY RECOMBINANT VACCINES, 2017-2032 (USD MILLION)
TABLE 358. GERMANY POULTRY VACCINE MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 359. GERMANY POULTRY VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 360. GERMANY POULTRY VACCINE MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 361. GERMANY POULTRY VACCINE MARKET SIZE, BY SPRAY, 2017-2032 (USD MILLION)
TABLE 362. GERMANY POULTRY VACCINE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. GERMANY POULTRY VACCINE MARKET SIZE, BY COMMERCIAL FARMS, 2017-2032 (USD MILLION)
TABLE 364. GERMANY POULTRY VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 365. GERMANY POULTRY VACCINE MARKET SIZE, BY ONLINE CHANNELS, 2017-2032 (USD MILLION)
TABLE 366. GERMANY POULTRY VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 367. GERMANY POULTRY VACCINE MARKET SIZE, BY VETERINARY PHARMACIES, 2017-2032 (USD MILLION)
TABLE 368. FRANCE POULTRY VACCINE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 369. FRANCE POULTRY VACCINE MARKET SIZE, BY VACCINE TYPE, 2017-2032 (USD MILLION)
TABLE 370

Companies Mentioned

  • Biogénesis Bagó S.A.
  • Bioproperties Pty Ltd
  • Biovet S.A.
  • Bioveta, a.s.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • China Animal Husbandry Industry Co., Ltd.
  • CZ Veterinaria S.A.
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA S.A.
  • Huvepharma EAD
  • Indian Immunologicals Ltd.
  • Indovax Private Limited
  • Jinyu Bio-Technology Co., Ltd.
  • KM Biologics Co., Ltd.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • SAN Group Biotech Germany GmbH
  • Tianjin Ringpu Bio-Technology Co., Ltd.
  • Vaksindo Satwa Nusantara
  • Vaxxinova International B.V.
  • Venky's India Limited
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.
  • Zydus Animal Health Limited

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.37 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Poultry Vaccines Market Size, Share, Trends and Forecast by Disease, Product, Dosage Form, Application, End User, and Region, 2026-2034 - Product Image

Poultry Vaccines Market Size, Share, Trends and Forecast by Disease, Product, Dosage Form, Application, End User, and Region, 2026-2034

  • Report
  • 138 Pages
  • Global
From
Poultry Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Poultry Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 114 Pages
  • Global
From
Poultry Vaccines Market Report 2026 - Product Image

Poultry Vaccines Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Poultry Vaccines Market - Global Strategic Business Report - Product Image

Poultry Vaccines Market - Global Strategic Business Report

  • Report
  • 602 Pages
  • Global
From
Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From

About the Poultry Vaccine Market

The Poultry Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and production of vaccines for poultry. Vaccines are used to protect poultry from diseases, such as avian influenza, Newcastle disease, and Marek's disease. Vaccines are typically administered through injection or spray, and can be used to protect both commercial and backyard poultry. The poultry vaccine market is driven by the increasing demand for poultry products, as well as the need to protect poultry from diseases. Additionally, the growing awareness of animal health and welfare, as well as the increasing demand for organic and free-range poultry products, are expected to drive the market. Companies in the poultry vaccine market include Merck Animal Health, Zoetis, Elanco, Ceva Sante Animale, and Boehringer Ingelheim. Additionally, there are several smaller companies that specialize in the production of poultry vaccines. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.